for people ages 50-80 (full criteria)
study started
estimated completion
Principal Investigator
by Gelareh Sadigh, MD



Lung cancer is the leading cause of cancer related mortality. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases mortality rate of lung cancer by 20%. Yet many patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test the effect of a a multi-level intervention on ordering LDCT within 6 months after patient enrollment. Our proposed intervention includes (1) Primary care provider notifications of patients' LCS eligibility; (2) patients' education ; (3) patients' referral to financial navigation resources; and (4) patients' reminder to discuss LCS during PCP visit.

Official Title

Empowering Patients' Lung Cancer Screening Uptake (Empower LCS)


Lung Cancer, Lung Neoplasms, Patient education, Referral to financial navigation resources, Provider Reminers, Empower LCS


You can join if…

Open to people ages 50-80

  1. Aged 50- 80 years of age.
  2. Be able to Speak English, Spanish, or Vietnamese
  3. Must have a scheduled appointment with their Primary Care Providers with in next one to three months.
  4. The Scheduled PCP appointment is at any of the UCI Health primary care clinics in Orange County including two UCI federally qualified health centers
  5. History of 20 pack year smoking history ( based on survey self report)
  6. Current smoker or a former smoker who has quit smoking within the last 15 years (based on survey self report)

You CAN'T join if...

1 No prior history of lung cancer 2, No chest CT for any reason in the last 12 months based on self-report and UCI EMR 3,No history of Alzheimer's disease or dementia

Lead Scientist at UC Irvine

  • Gelareh Sadigh, MD
    Associate Professor In Residence, Radiological Sciences, School of Medicine. Authored (or co-authored) 91 research publications


not yet accepting patients
Start Date
Completion Date
University of California, Irvine
Study Type
Expecting 80 study participants
Last Updated